MedPath

Nafcillin

Nafcillin for Injection, USP

Approved
Approval ID

fda15ff5-1b77-4207-80ed-38d12c540b3f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 18, 2011

Manufacturers
FDA

Claris Lifesciences, Inc.

DUNS: 808114537

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nafcillin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code36000-176
Application NumberANDA090560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateOctober 18, 2011
FDA Product Classification

INGREDIENTS (2)

SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
NAFCILLIN SODIUMActive
Quantity: 2 g in 1 1
Code: 49G3001BCK
Classification: ACTIM

Nafcillin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code36000-175
Application NumberANDA090560
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nafcillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateOctober 18, 2011
FDA Product Classification

INGREDIENTS (2)

NAFCILLIN SODIUMActive
Quantity: 1 g in 1 1
Code: 49G3001BCK
Classification: ACTIM
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nafcillin - FDA Drug Approval Details